Allergan logo

AGN - Allergan Share Price

$188.34 0.1  0.0%

Last Trade - 13/12/19

Sector
Healthcare
Size
Large Cap
Market Cap £46.40bn
Enterprise Value £59.90bn
Revenue £11.87bn
Position in Universe 167th / 6397
Bullish
Bearish
Unlock AGN Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

AGN Revenue Unlock AGN Revenue

Net Income

AGN Net Income Unlock AGN Revenue

Normalised EPS

AGN Normalised EPS Unlock AGN Revenue

PE Ratio Range

AGN PE Ratio Range Unlock AGN Revenue

Dividend Yield Range

AGN Dividend Yield Range Unlock AGN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AGN EPS Forecasts Unlock AGN Revenue
Profile Summary

Allergan plc is a specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and over-the-counter pharmaceutical products. The Company operates through three segments: US Specialized Therapeutics, US General Medicine and International. The US Specialized Therapeutics segment includes sales relating to branded products within the United States, including Medical Aesthetics, Medical Dermatology, Eye Care, Neurosciences and Urology therapeutic products. The US General Medicine segment includes sales relating to branded products within the United States that do not fall into the US Specialized Therapeutics business units, including Central Nervous System, Gastrointestinal, Women's Health, Anti-Infectives and Diversified Brands. The International segment includes sales relating to products sold outside the United States.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated May 16, 2013
Public Since October 1, 2013
No. of Shareholders: 3,176
No. of Employees: 16,900
Sector Healthcare
Industry Pharmaceuticals
Index S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 328,277,336
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AGN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for AGN
Upcoming Events for AGN
Monday 27th January, 2020 Estimate
Q4 2019 Allergan plc Earnings Release
Tuesday 5th May, 2020 Estimate
Q1 2020 Allergan plc Earnings Release
Similar to AGN
© Stockopedia 2019, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.